The Mumbai-based drug major has recently signed an agreement with ICMR and Madhya Pradesh government to work towards eradicating malaria
Sun Pharma has significant investment plans for its facility in Madhya Pradesh, the firm’s Managing Director Dilip Shanghvi said. “We have significant additional investments plans for our Madhya Pradesh facility, including setting up of a new research facility in Madhya Pradesh,” Shanghvi said at the Global Investors Summit here. He said the company is present in the state because of Ranbaxy, which has a large manufacturing facility here. Sun Pharma had acquired Ranbaxy in a $4-billion deal in 2014.
The Mumbai-based drug major has recently signed an agreement with ICMR and Madhya Pradesh government to work towards eradicating malaria, which will facilitate the Centre’s commitment to eradicate malaria in India by 2030.
PTI
- Advertisement -
Comments are closed.